![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Intralytix Receives FDA Clearance for Phage-Based Shigella Technology
Intralytix Receives FDA Clearance for Phage-Based Shigella Technology
![Green_Light.gif](https://www.fdanews.com/ext/resources/test/Device_Images5/Green_Light.gif?t=1625610540&width=430)
April 7, 2017
Baltimore–based Intralytix has received FDA marketing clearance for ShigaShield, an antimicrobial preparation for controlling the foodborne/waterborne bacterial pathogen Shigella.
The company already has three approved phage-based products on the market: the ListShield, EcoShield and SalmoFresh.
The active ingredients of ShigaShield are bacteriophages that selectively kill Shigella species, including strains belonging to the species of Shigella: S. flexneri, S. sonnei and S. dysenteriae. — Cynthia Jessup
Upcoming Events
-
21Oct